The Challenge of Insulin Titration

Slides:



Advertisements
Similar presentations
In the name of GOD In the name of GOD.
Advertisements

What's New in Basal Insulin for Diabetes
Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.
Short-, Intermediate-, Long-Acting Insulins
Diabetic Dyslipidemia in Practice
Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.
Applying Data to Practice
Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?
Faster-Acting Insulins
Program Goals. Inhaled Insulin: Overcoming Past Obstacles With Advances in Understanding.
Using the AGP to Standardize Glucose Reporting
New Patient-Friendly Options for Managing Insulin Dosing
Does One Size Fit All in Obesity Management?
The Next Generation of Basal Insulins
Modern Strategies for Basal Insulin Use in T2D
Insulin Innovation.
Insulin/GLP-1 Agonist Combinations
Insulin Intensification Strategies in Later-Stage Type 2 Diabetes Mellitus.
How Early Should Basal Insulin Be Used in T2D Management?
Novel Concentrated Insulins: What Benefits and for Which Patients?
T-Cell Directed Therapy in MS
Examining CV Effects of Basal Insulin Therapy
What Do Primary Care Physicians Need to Know About Insulin/GLP-1 RA Fixed-Ratio Combinations?
Innovative Insulin Combinations: A New strategy for the Person With T2DM.
Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?
Emerging Basal Insulins for Diabetes
Insights into Insulin Treatment Challenges: Real-World Evidence and Clinical Trial Data.
GLP-1 Receptor Agonists: How Early Is Appropriate?
Novel Insulin Combinations: What Does the Primary Care Physician Need to Know?
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
Insulin/GLP-1 Agonist Combinations
Insulin Innovation.
New Horizons in Adjunctive Type 1 Diabetes Management With SGLT Inhibitors.
EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.
Predictive Low Glucose Suspend (PLGS)
Novel Approaches to T1D Management
The Evolving Treatment Landscape in Atopic Dermatitis
T2DM Management.
Better Diabetes Control With Novel Basal Insulins
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Program. Basal Insulin in the Modern Era The CDE's Role in Improving Utilization and Outcomes.
Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.
Dual SGLT1/SGLT2 Inhibition in T1D
Advancements in Glucose Monitoring
Insulin Innovation.
Typical Patient Presentation
PEARLS OF WISDOM WITH COMBINATION THERAPY IN PAH
Oral Prostacyclin Pathway Agents in PAH
COMBINATIONS AND COFORMULATIONS: THE FUTURE OF INSULIN THERAPY?
Liraglutide Shows CV Benefit: Clinical Perspectives on the LEADER Trial
Glucose Management and Statin Therapy
Iron Deficiency in Heart Failure
Add-On Therapy to Insulin in T1DM Management
Incorporating Prostacyclins Into Practice
Improving Effective Basal Insulin Use in Clinical Practice
Are All Novel Insulins Proven to Be Equally Safe?
Glucose Management and Statin Therapy
PAH Pathways: What Do the Data Tell Us?”
A Closer Look.
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors.
Identifying TRK Fusions in Head and Neck Cancer
Fixed-Ratio Combination Therapy in T2DM
Risk Stratification of Patients With Type 2 Diabetes: An Interpretation of the Latest Treatment Guidelines.
Expert Perspectives.
Comparative Studies of Biologics in Ulcerative Colitis
Examining the Role of Pharmacokinetics in Hemophilia
Emerging Basal Insulins for Diabetes
Fresh perspectives ON BASAL Insulins in diabetes care
The Power of As-Treated Analyses
Presentation transcript:

The Challenge of Insulin Titration

Program Overview

Delays in Titration of Basal Insulin

Titration of Basal Insulin -- HCPs Need to Share More Information With Patients

The Benefits of Insulin Titration

The Evolution of Basal Insulins

Trial-Level Meta-Analyses of Nocturnal Hypoglycemia With Deg-100 and Gla-300

Comparing PK/PD Data

BRIGHT: Head-to-Head Comparison of Gla-300 and Deg-100

BRIGHT: Study Endpoints and Glycemic Targets

BRIGHT Results: Glycemic Control and Weight Changes

BRIGHT: Anytime (24 h) Hypoglycemia

BRIGHT: Nocturnal (00:00 to 06:00 h) Hypoglycemia

RCT Data: Implications for Clinical Practice

The Role of RCTs and RWE

The Role of RCTs and RWE (cont)

Patient-Led Titration of Basal Insulin: TAKE CONTROL

Patient-Led Titration of Basal Insulin: TAKE CONTROL (cont)

Implications of RCTs and TAKE CONTROL for Basal Insulin Titration

Other RWE for Second-Generation Basal Insulins

Basal Insulin Titration in Clinical Practice

How Clinicians Can Help Patients Take Control of Titration

Conclusions

Abbreviations

Abbreviations (cont)